Martin Hunt
Medtech Industry Engagement Adviser, NIHR

About me


Martin has over 35 years’ experience in the life science industry, with executive and NED roles in large multi-nationals, SMEs and public companies. During 15 years in international Medtech companies, he had senior roles in sectors including ophthalmic surgery, wound management and chronic care. He joined Tissue Science Laboratories as Chief Executive in 1999 and led the company from a start-up, through angel funding, a listing on the AiM market in 2001 through to trade sale in 2008. Since then, he has been Chair, NED or investor on the Boards of nine early stage Medtech, Biotech and Diagnostic companies and is currently Chair of two, with technologies in regenerative medicine and skin microbiome.
Martin has worked extensively with the University sector, advising on technology transfer and commercialisation of innovative technologies. He is a member of the Bioengineering Advisory Board, Imperial College London and the Imperial Technology Experts Service. Martin was an Impact Assessor on the Clinical Medicine Panel for the UK Government Research Excellence Framework exercise during 2014.
Martin is also Programme Director of NIHR Invention for Innovation, a translational funding programme. i4i aims to support and advance the research and development of innovative healthcare technologies and their translation into the clinical environment for the benefit of patients. The programme has a current portfolio of c£170m invested in 200+ projects and has leveraged additional funding of over £94m. Martin is also a member of the NIHR Strategy Board, and is Chair or Board member of a number of NIHR initiatives.

Martin has raised over £50m public / private funding to support innovative technologies and is an active business angel.

Matchmaking Information

Processing. Please wait.